Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Atkore Inc (NYSE: ATKR), which manufactures electrical products for commercial, industrial, data center, telecommunications and solar applications, said on Tuesday that David Johnson had resigned as Vice President, Chief Financial Officer and Chief Accounting Officer, effective August 9th.

In connection with Johnson’s departure from the firm, John Deitzer has been appointed as Vice President and Chief Financial Officer, while James Alvey – as Chief Accounting Officer.

Most recently, Deitzer served as Vice President of Finance – Electrical business unit at Atkore.

He joined the firm in 2019, assuming the role of Vice President of Investor Relations.

Before that, John Deitzer was four years at Alcoa Corporation, assuming Investor Relations and Management Consulting & Strategy roles.

“On behalf of Atkore, I thank David for his numerous contributions during the past six years,” Bill Waltz, President and Chief Executive Officer of Atkore Inc, said in a press release.

“Under his leadership, Atkore has created a balanced capital deployment model enabling acquisitions, internal investments, stock repurchases and quarterly dividends. Adhering to this disciplined financial management in combination with our standard organizational leadership succession planning will certainly provide for a smooth transition of responsibilities.”

Stock Performance

The shares of Atkore Inc (ATKR) closed 0.30% ($0.43) higher at $145.00 in New York on Tuesday, as they extended the gain from the previous market session.

The company’s total market cap now stands at $5.282 billion.

The shares of Atkore Inc (ATKR) went up 41.07% in 2023, compared with a 10.99% gain for the benchmark index, NYSE Composite (NYA).

The company’s shares have retreated 9.37% so far this year.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Copper falls amid higher-than-expected supplyCopper falls amid higher-than-expected supply Copper fell on Wednesday as producers reported higher-than-expected output, spurring concern over ample supply. Stronger dollar also weighed on prices.On the Comex division of the New York Mercantile Exchange, copper futures for September […]
  • Forex Market: EUR/JPY daily outlookForex Market: EUR/JPY daily outlook During yesterday’s trading session EUR/JPY traded within the range of 140.19-141.04 and closed at 140.38.At 8:47 GMT today EUR/JPY was losing 0.22% for the day to trade at 140.10. The pair broke the first key support and recorded a daily […]
  • US Dollar retreats against the YenUS Dollar retreats against the Yen The US dollar traded lower versus Japanese Yen today, as most investors took their profits. USD/JPY cross slided down to 101.27 during the Asian session, which is the pairs lowest level since Friday . Support levels were fixed around […]
  • United Parcel shares fall for a second straight session on Thursday, Carol Tomé named UPS’ next Chief Executive OfficerUnited Parcel shares fall for a second straight session on Thursday, Carol Tomé named UPS’ next Chief Executive Officer United Parcel Service Inc (UPS) said on Thursday that Carol Tomé had been appointed as its next Chief Executive Officer, effective June 1st. Tomé will replace David Abney, who presently is also Chairman of the Board.United Parcel […]
  • Forex Market: USD/CAD daily trading forecastForex Market: USD/CAD daily trading forecast Yesterday’s trade saw USD/CAD within the range of 1.3034-1.3168. The pair closed at 1.3060, falling 0.27% on a daily basis. It has been the fifth loss in the past seven trading days. The daily low was a lower-low test of October 23rd low and, […]
  • Onyx rejects Amgen offer, still looking for a mergerOnyx rejects Amgen offer, still looking for a merger Onyx Pharmaceuticals, the bio-pharmaceutical company developing cancer drugs, rejected an acquisition offer from Amgen the world largest independant bio-pharmaceutical firm for around $10 billion. The company stated it is waiting on better […]